Introduction {#s1}
============

Kidney stone disease (nephrolithiasis) remains a common health problem worldwide [@pone.0101306-Coe1]. The exact formation mechanism of renal stones is complex and remains indistinct. Hyperoxaluria is a common finding in stone patients. The most common pathological condition involving oxalate is the formation of calcium oxalate stones in the kidney. Among all types of kidney stones, calcium oxalate monohydrate (COM) is the major crystalline compound in the stone formation (at a frequency of up to 77.5%) [@pone.0101306-Schubert1]. In addition to crystallization, crystal growth and crystal aggregation, the crucial mechanism for COM kidney stone formation is the adhesion of COM crystals to renal tubular epithelial cells [@pone.0101306-Sheng1], [@pone.0101306-Rabinovich1]. Adhesion of COM crystals can induce injury and apoptosis of renal epithelial cells. Meanwhile, COM-induced cellular injury can facilitate COM crystal adhesion [@pone.0101306-Khan1], [@pone.0101306-Asselman1]. The vicious cycle therefore accelerates kidney stone formation. Understanding the alterations in renal tubular cells induced by COM crystals may lead to an identification of molecular targets for the prevention of kidney stone formation. However, changes in renal tubular epithelial cells under the influence of COM crystal-induced toxicity remain ambiguous.

MicroRNAs (miRNAs), a recently identified class of posttranscriptional gene regulators, may play an important role in COM crystal induced alteration of gene expression. MiRNAs are a group of small (20--22 nt) endogenous non-protein-coding RNA molecules that negatively regulate gene expression [@pone.0101306-Ambros1], [@pone.0101306-Zhang1]. These miRNAs usually bind to the 3′-untranslated region (3′-UTR) of target mRNA which leads to mRNA cleavage or translation inhibition [@pone.0101306-Ambros2]. It has also been predicted that miRNAs target more than 30% protein-coding genes [@pone.0101306-Lewis1]. However, there is no report on the effect of COM crystals on miRNAs in nephrolithiasis. Considering the potential roles of miRNAs in nephrolithiasis, we hypothesized that the cytotoxicity of COM crystals on HK-2 cells may be partially elicited by the regulation of miRNA expression levels. To our knowledge, this study presents the first miRNA analysis of human renal tubular cells injured by COM crystals. In this study, miRNA, mRNA microarray technology and quantitative real-time PCR (qRT-PCR) were used to investigate the effect of COM crystals exposure on the global expression profile of miRNAs in HK-2 cell line. We successfully identified some miRNAs that might help improve our understanding of the pathogenesis associated with stone formation, and more specifically, with the interactions between COM crystals and renal cells.

Materials and Methods {#s2}
=====================

Cell Culture {#s2a}
------------

Human Kidney Epithelial Cells, HK-2, were procured from American Type Culture Collection (ATCC) and maintained in a DMEM medium supplemented with 10% Fetal Bovine Serum and antibiotics. Before COM crystals treatment, cells were serum starved for 12 hours. Media components were procured from Invitrogen Corporation and all other chemicals were procured from Sigma-Aldrich.

Preparation of COM Crystals {#s2b}
---------------------------

COM crystals were prepared by mixing equal volumes of 10 mM calcium chloride (CaCl~2~) and 10 mM sodium oxalate (Na~2~C~2~O~4~). The mixture was incubated overnight and COM crystals were harvested by centrifugation at 3000 rpm for 5 min. COM crystals were then decontaminated by UV light radiation for 30 min. These in vitro COM crystals had similar size and shape as those in vivo samples found in the urine of kidney stone patients.

Cell Exposure {#s2c}
-------------

Prior to being used in experiments, COM crystals were resuspended to remove the aggregation between crystals. Confluent cells were treated with COM crystals at the concentration of 0, 0.1 mmol/L, 1 mmol/L and 10 mmol/L for 24 h. The media were collected for LDH assay, and then the cells were stained with DAPI. Cells treated with 1 mmol/L COM crystals for 24 h were used for miRNA and mRNA microarray.

LDH Assay {#s2d}
---------

Lactate dehydrogenase is a stable cytosolic enzyme which is released when there is injury on the cell membrane. The LDH which were released into the media was assessed by measuring LDH activity spectrophotometrically by lactate to pyruvate reaction. Reaction solutions contained collected media, 160 mM lactate, 25 mM NAD, 200 mM glycine-hydrazine buffer, PH 9.5. The absorbance at 340 nm was monitored for 60 min.

Apoptosis Assay {#s2e}
---------------

HK-2 cells were grown in 6-well glass slides and when the cells were confluent. They were exposed to different concentrations of COM crystals (0, 0.1, 1, 10 mmol/L). The cells in the wells were washed with PBS, fixed with 1% formaldehyde for 10 min at room temperature, stained with 4′6-diamidino-2-phenylindole (DAPI) for two min and washed with PBS for 5 min. Cells were observed under the fluorescence microscope (Zeiss, Germany).

RNA Isolation {#s2f}
-------------

HK-2 cells were treated with 1 mmol/L COM crystals, the samples were collected at 24 h after treatment. Cells treated with the same medium without COM crystals were used as the negative control. All samples were lysed in Trizol. RNA was extracted through the procedures recommended by the manufacture (Invitrogen, Carlsbad, USA) and DNA containment was removed through DNase digestion. RNA quality was confirmed by Agilent bioanalyzer 2100.

miRNA Microarray and mRNA Microarray {#s2g}
------------------------------------

The Agilent human miRNA microarrays (version 16.0) were used to compare the expression profile of control and COM crystals treated cells. 5 µg of total RNA was used for hybridization of miRNA microarray chip which contained 1205 human miRNAs (Shanghai Biochip Co.Ltd., China). The miRNA microarrays data discussed in this paper had been deposited in NCBI Gene Expression Omnibus and were accessible through GEO Series accession number GSE56934. mRNA expression profiles were analyzed using the Human lncRNA microarray v2.0 (Arraystar Company, USA). This microarray contained 30215 human mRNAs. The microarray data had been deposited in NCBI Gene Expression Omnibus and were accessible through GEO Series accession number GSE57111.

Real-time RT-PCR {#s2h}
----------------

For miRNA detection, bulge-loop^tm^ miRNA qRT-PCR Primer Sets (one RT primer and a pair of qPCR primers for each set) specific for hsa-miR-638, has-miR-3125, hsa-miR-3195, hsa-miR-1260 and hsa-miR-371-5p, hsa-miR-933, and hsa-miR-4284 were designed by RiboBio (Guangzhou, China). For mRNA, total RNA was extracted and reversely transcribed to cDNA. PCR was carried out according to standard protocol of SYBR Premix Ex Taq with the aid of real-time PCR equipment. U6 and GAPDH were used as the negative control of miRNA and mRNA respectively. All the reactions were run in triplicate.

Target Prediction and Function Analysis {#s2i}
---------------------------------------

The most dysregulated miRNAs after COM crystal exposure were selected for target prediction. TargetScan was used to predict the putative targets. The lists of potential gene targets for each selected miRNA were classified according to their biological functions which were determined by Gene Ontology system (<http://www.geneontology.org/>). To determine the possible overlapping of biological functions among these miRNAs, significantly overrepresented GO terms among all predicted gene targets for each individual miRNA were searched by means of the GOstat software. The program determined all the annotated GO terms associated with the target genes, and then counted the number of appearances of each GO term for these genes. A Fischer\'s exact test was then performed to give the *p*-value for each GO term, representing the probability that the observed counts could have been due to chance. In addition, Pathway analysis of the target genes was performed by using the DAVID Bioinformatics Resources 2008 (<http://david.abcc.ncifcrf.gov/>). The program groups together related the annotations (GO terms) for a similar set of genes, compared the GO processes if they might be related to a biological network and compiled a list of potential pathways for the effects of the target genes.

Statistical Analysis {#s2j}
--------------------

The continuous variables were expressed as the mean values±standard deviations (SD). Comparisons between the samples (control vs COM-exposed cells) were performed using one-way ANOVA followed by LSD\'s post hoc test. *P*\<0.05 was considered statistically significant.

Results {#s3}
=======

LDH Release {#s3a}
-----------

The release of LDH was measured as a marker for plasma membrane damage. Exposure to 1 mmol/L COM crystals for 24 h resulted in significantly higher levels of LDH released into media. Increased levels of LDH were measured in response to 10 mmol/L COM crystals ([Figure 1](#pone-0101306-g001){ref-type="fig"}). As expected, LDH release in response to COM crystals was concentration dependent.

![COM crystals increased LDH release from HK-2 cells.\
HK-2 cells were incubated with different concentrations (0, 0.1, 1, 10)mmol/L of COM for 24 h in triplicate samples to determine LDH activity released into media. Symbol (\*) indicates significant difference from 0-control (*P*\<0.05).](pone.0101306.g001){#pone-0101306-g001}

Apoptosis Assay {#s3b}
---------------

COM crystals induced cytotoxicity in HK-2 cells. Condensed nuclei and apoptotic bodies were showed with DAPI staining after treatment with 1 mM COM crystals for 24 h ([Figure 2](#pone-0101306-g002){ref-type="fig"}). After treated with 10 mM COM crystals for 24 h, HK-2 cells showed highly condensed chromatin and many cell fragments. Based on the results of LDH release and apoptosis assay, we used 1 mM as the proper concentration for subsequent experiments.

![Cells in culture were examined by flurorescence microscopy following staining with DAPI.\
A Cells treated with 0(magnification, ×200).](pone.0101306.g002){#pone-0101306-g002}

Alteration of miRNA Expression Profiles in HK-2 Cells after COM Crystals Treatment {#s3c}
----------------------------------------------------------------------------------

Treatment with COM crystals significantly altered the miRNA expression profiles in HK-2 cells. We used the Agilent Human miRNA Microarray V16.0. This microarray has 1205 human miRNAs. 25 miRNAs were differentially expressed with a more than 1.5-fold change ([Table 1](#pone-0101306-t001){ref-type="table"}). Among these miRNAs, 16 miRNAs were up-regulated, while 9 miRNAs were down-regulated.

10.1371/journal.pone.0101306.t001

###### Dysregulated miRNAs after COM crystals exposure.

![](pone.0101306.t001){#pone-0101306-t001-1}

  Probe_ID          foldchange      Probe_ID      Foldchange
  ---------------- ------------ ---------------- ------------
  Up-regulated                   Down-regulated  
  hsa-miR-371-5p     3.069941    hsa-miR-425\*     0.069018
  hsa-miR-3125       2.71054     hsv1-miR-H6-3p    0.071335
  hsa-miR-638        2.682127    hsv1-miR-H7\*     0.078529
  hsa-miR-3195       2.251545     hsa-miR-933     0.09623093
  ebv-miR-BART13     2.155447    hsa-miR-191\*     0.303036
  hsa-miR-135a\*     2.078597    hsa-let-7f-1\*    0.366442
  hsa-miR-1274b      2.004063     hsa-miR-4284     0.393521
  hsa-miR-497        1.918096     hsa-miR-4313     0.485941
  hsa-miR-1181       1.829789     hsa-let-7b\*     0.48814
  hsa-miR-195        1.706755                    
  hsa-miR-1260b      1.693521                    
  hsa-miR-21\*       1.688719                    
  hsa-miR-642b       1.644018                    
  hsa-miR-1260       1.585072                    
  hsv1-miR-H8        1.532887                    
  hsa-miR-1274a      1.505559                    

miRNA cloning studies sometimes identify two ∼22 nt sequences miRNAs which originate from the same predicted precursor. When the relative abundancies clearly indicate which is the predominantly expressed miRNA, the mature sequences are assigned names of the form miR-56 (the predominant product) and miR-56\* (from the opposite arm of the precursor). So the \* means the product is from the opposite arm of the precursor. (<http://www.mirbase.org/help/nomenclature.shtml>).

To validate the data obtained from miRNA microarray, qRT-PCR was performed on seven differentially expressed miRNAs (five up-regulated: hsa-miR-638, has-miR-3125, hsa-miR-3195, hsa-miR-1260 and hsa-miR-371-5p; two down-regulated: hsa-miR-933, hsa-miR-4284) and the results from microarray and qRT-PCR were compared. As showed in [Figure 3](#pone-0101306-g003){ref-type="fig"}, hsa-miR-638, has-miR-3125, hsa-miR-3195, has-miR-1260 and has-miR-371-5p were up-regulated, while hsa-miR-933, hsa-miR-4284 were down-regulated according to the qRT-PCR data. The results were comparable with the microarray data and thus validated the results for miRNAs obtained from miRNA microarray.

![qRT-PCR was performed to confirm the expression of 7 selected miRNAs of HK-2 cells induced by COM crystals.\
The selected miRNAs included 5 up-regulated miRNAs and 2 down-regulated miRNAs.](pone.0101306.g003){#pone-0101306-g003}

To test the potential effect of different intervals of COM crystals on miRNA expression profiles, we selected four differentially expressed miRNAs (hsa-miR-638, hsa-miR-1260, hsa-miR-371-5p and hsa-miR-4284) to monitor their expression levels at 0 h, 12 h, 24 h and 48 h. [Figure 4](#pone-0101306-g004){ref-type="fig"} showed a time-dependent regulation of miRNA expression in response to COM crystals treatment. hsa-miR-371-5p showed an initial increase at 12 h, which reached its top at 24 h after being exposed. At 48 h, the expression began to decrease compared with that at 24 h. The expression of hsa-miR-638 showed the same pattern of hsa-miR-371-5p. Besides, the expression of hsa-miR-1260 was almost the same at each time point (12 h, 24 h and 48 h). The expression of hsa-miR-4284 decreased sharply at 12 h, which reached its peak at 24 h. At 48 h, the expression of this miRNA was almost the same compared with that at 24 h.

![Expression profiles of 4 selected miRNAs of HK-2 cells induced by COM crystals with different time points.](pone.0101306.g004){#pone-0101306-g004}

Identification of mRNA Expression Profiles in HK-2 Cells after COM Crystals Treatment {#s3d}
-------------------------------------------------------------------------------------

To explore the impact of gene expression, we further studied the mRNA expression patterns of HK-2 cells treated with COM crystals by using the human lncRNA microarray v2.0 (Arraystar Company, USA). The microarray has 30215 human mRNAs. In total, 2592 genes were identified as differentially expressed ([Table 2](#pone-0101306-t002){ref-type="table"}). Among these genes, 1764 were up-regulated, while 828 were down-regulated. 11 genes were differentially up-regulated with a more than 16-fold change. The top 10 up-regulated genes were IRX6, CLIP1, MMP25, CCL3, C10orf107, PLEC, CCL3L1, CCL3L3, TNF and KRTAP11-1. 87 genes were differentially down-regulated with a more than 16-fold change. The top 10 down-regulated genes were CTDSP2, QRICH2, NINL, USP37, C8orf86, PPEF1, KIAA1310, TRIM36, FDPS, RAPH1. ([Table 3](#pone-0101306-t003){ref-type="table"})

10.1371/journal.pone.0101306.t002

###### Summary of data from mRNA microarray.

![](pone.0101306.t002){#pone-0101306-t002-2}

                                  mRNAs             
  ----------------- ------ ----- -------- --------- ------
  Up-regulation      1361   392     11      1764     2592
  down-regulation    466    275   **87**   **828**  

10.1371/journal.pone.0101306.t003

###### Dysregulated mRNAs after COM crystals exposure.

![](pone.0101306.t003){#pone-0101306-t003-3}

  Up-regulated                Down-regulated  
  -------------- ----------- ---------------- ------------
  IRX6            8.485357        CTDSP2       -10.556264
  CLIP1           5.7348537       QRICH2       -8.124645
  MMP25           5.0595646        NINL        -7.7819004
  CCL3            4.8733883       USP37        -7.639219
  C10orf107       4.7241697      C8orf86       -6.735654
  PLEC            4.6747723       PPEF1        -6.5349064
  CCL3L1          4.6711597      KIAA1310      -5.998905
  CCL3L3          4.585658        TRIM36       -5.6827116
  TNF             4.5506287        FDPS        -5.438601
  KRTAP11-1       4.447587        RAPH1        -5.268367

To validate the microarray data, four differentially expressed genes were randomly chosen for qRT-PCR (two up-regulated: IRX6, CCL3; two down-regulated: CTDSP2, QRICH2) ([Figure 5](#pone-0101306-g005){ref-type="fig"}). Our results were comparable with the microarray data and thus validated the results for mRNAs obtained from mRNA microarray.

![qRT-PCR was performed to confirm the expression of 4 selected mRNAs of HK-2 cells induced by COM crystals.\
The selected mRNAs included 2 up-regulated mRNAs and 2 down-regulated mRNAs.](pone.0101306.g005){#pone-0101306-g005}

Integrated Analysis of Deregulated miRNAs and mRNAs {#s3e}
---------------------------------------------------

MiRNAs modulate gene expression through mRNA degradation or translation repression. Therefore, we performed an integrated analysis of miRNA and mRNA expression patterns. The computational program, TargetScan, was utilized to predict the target genes. These genes were compared with those from mRNA microarray. Among the 2592 differentially expressed mRNAs, 114 genes were the predicted targets of the 12 differential miRNAs ([Table 4](#pone-0101306-t004){ref-type="table"}). Some of the genes were related to cell death, mitochondrion and metabolic process.

10.1371/journal.pone.0101306.t004

###### The genes both contained in mRNA chips and miRNAs prediction.

![](pone.0101306.t004){#pone-0101306-t004-4}

  Gene name                                                                                                                                                                                                                                        Description
  ----------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  hsa-miR-933                                                                                                                                                                                                                           NR4A1 MBP PLXNA1 C19orf25 MID1IP1
  hsa-miR-642b                                                                                                                                                                                                                        SEMA3A PRDM4 C9orf91 AK3L1 ENO2 CIDEA
  hsa-miR-638                                                                                                                                                                                                       CHRNB4 EXOC7 GPX1 SMAP2 CHAC1 CPNE1 CHD3 CAPN10 ENO2 CNPY4 PLXNA1 LMBR1L
  hsa-miR-497        SEMA3A SPON2 PRDM4 SFRS16 CHRNB4 CPXM2 CMTM3 TMEM174 FAM122B C11orf42 C9orf91 AK3L1 EXT2 PUF60 EXOC7 FUT3 CCDC19 FAM32A GLS2 PDCD4 SLC13A5 CYB561D1 RSPO1 GPX1 THYN1 GSR HMOX2 NR4A1 C1QL4 APP ITIH1 KARS KRT33B LDHA MAGEB4 MBP ASB1 CMPK1 PGM1 AURKAIP1 PPP1R2 PRKAR2A C12orf4 USP31 TGIF2 RFWD2 GORASP1 SMAP2 MRPL40 SNRPA1 SSRP1 TTC1 ZYX CHAC1 C13orf18 POLDIP3 CUL2 SLITRK2 SPRYD3 NAE1 EIF2S2 CPNE1 CCNE1 C1orf38 NCOR2 KIAA0430 DEPDC5 BZW1 SCRN1 CDC25A TSGA13
  hsa-miR-4313                                                                                                                        SEMA3A PRDM4 CMTM3 C11orf42 C9orf91 PDCD4 CYB561D1 RSPO1 THYN1 HMOX2 MBP CMPK1 TGIF2 GORASP1 ZYX POLDIP3 SPRYD3 CCNE1 NCOR2 SCRN1 CDC25A TSGA13 CCT3 CLPTM1L EI24 C19orf25 MID1IP1 ZNF384 GPR114 B4GALT2 TMEM44 PDIA4 C1orf162 CIDEA
  hsa-miR-4284                                                                                                                                                                      CHRNB4 CPXM2 CMTM3 FAM122B CYB561D1 RSPO1 GSR TGIF2 RFWD2 C13orf18 POLDIP3 CUL2 DEPDC5 BZW1 LMBR1L CCR6 NDUFV3 CCT3 FOXM1 C1orf162 CIDEA
  hsa-miR-371-5p                                                                                                                                                  SEMA3A FAM122B C9orf91 AK3L1 SLC13A5 RSPO1 GSR LDHA MBP ASB1 CMPK1 PPP1R2 C13orf18 CUL2 KIAA0430 BZW1 SCRN1 CDC25A CCR6 SGSM3 NDUFV3 NEK3 SUFU RPL37A CCT3 CLPTM1L GFI1B EI24
  hsa-miR-3663-3p                                                                                                                                                                      SPON2 CPXM2 CMTM3 C1QL4 CMPK1 SMAP2 MPPED1 CHAC1 C13orf18 POLDIP3 EIF2S2 NCOR2 CDC25A CNPY4 PLXNA1 CCR6 NDUFV3 ZNF384 GPR114 FOXM1
  hsa-miR-3125                                                                                                                                    PRDM4 CPXM2 C9orf91 EXT2 PUF60 FAM32A GLS2 GPX1 GSR KRT33B MBP CMPK1 PGM1 PPP1R2 PRKAR2A C12orf4 SMAP2 TTC1 SLITRK2 SPRYD3 KIAA0430 CHD3 ENO2 CNPY4 CCR6 SUFU RPL37A CLPTM1L GFI1B ZNF384 DTNB FOXM1 C1orf162
  hsa-miR-195        SEMA3A SPON2 PRDM4 SFRS16 CHRNB4 CPXM2 CMTM3 TMEM174 FAM122B C11orf42 C9orf91 AK3L1 EXT2 PUF60 EXOC7 FUT3 CCDC19 FAM32A GLS2 PDCD4 SLC13A5 CYB561D1 RSPO1 GPX1 THYN1 GSR HMOX2 NR4A1 C1QL4 APP ITIH1 KARS KRT33B LDHA MAGEB4 MBP ASB1 CMPK1 PGM1 AURKAIP1 PPP1R2 PRKAR2A C12orf4 USP31 TGIF2 RFWD2 GORASP1 SMAP2 MRPL40 SNRPA1 SSRP1 TTC1 MPPED1 ZYX CHAC1 C13orf18 POLDIP3 CUL2 SLITRK2 SPRYD3 NAE1 EIF2S2 CPNE1 CCNE1 C1orf38 NCOR2 KIAA0430 DEPDC5 BZW1 SCRN1 CDC25A
  hsa-miR-1260b                                                  SEMA3A PRDM4 TMEM174 FAM122B AK3L1 EXT2 EXOC7 FUT3 GLS2 PDCD4 SLC13A5 CYB561D1 NR4A1 APP MAGEB4 ASB1 PPP1R2 PRKAR2A C12orf4 USP31 TGIF2 GORASP1 SMAP2 SSRP1 MPPED1 CUL2 EIF2S2 C1orf38 NCOR2 DEPDC5 BZW1 SCRN1 CDC25A CHD3 CAPN10 ENO2 CNPY4 LMBR1L CCR6 SGSM3 NDUFV3 NEK3 SUFU GFI1B EI24 C19orf25 MID1IP1 OTOA ZNF384 DTNB GPR114 FOXM1 GPX4 NT5C SKAP1 B4GALT2 TMEM44 PDIA4
  hsa-miR-1260                                                   SEMA3A PRDM4 TMEM174 FAM122B AK3L1 EXT2 EXOC7 FUT3 GLS2 PDCD4 SLC13A5 CYB561D1 NR4A1 APP MAGEB4 ASB1 PPP1R2 PRKAR2A C12orf4 USP31 TGIF2 GORASP1 SMAP2 SSRP1 MPPED1 CUL2 EIF2S2 C1orf38 NCOR2 DEPDC5 BZW1 SCRN1 CDC25A CHD3 CAPN10 ENO2 CNPY4 LMBR1L CCR6 SGSM3 NDUFV3 NEK3 SUFU GFI1B EI24 C19orf25 MID1IP1 OTOA ZNF384 DTNB GPR114 FOXM1 GPX4 NT5C SKAP1 B4GALT2 TMEM44 PDIA4

The basic biological function of each putative gene was classified by means of the Gene Ontology system. Since every single gene was associated with many GO terms, the GOsat software was used to identify the overrepresented GO terms for each miRNA. [Table 5](#pone-0101306-t005){ref-type="table"} presents a few representative biological processes associated with each miRNA as predicted by the GOstat software. The putative targets of these miRNAs were then used for the pathway analysis performed by DAVID Bioinformatics Resources. The program provided potential functional pathways for the putative target genes of the selected miRNAs. Based on the target analysis, we found several important biological processes, such as apoptosis, regulation of RNA metabolic process, intracellular signaling cascade, regulation of kinase activity, I-kappaB kinase/NF-kappaB cascade, mitochondrion, response to wounding, regulation of transcription and ion binding transcription. These results suggested important roles these miRNAs played in human health and disease regulations. Furthermore, the pathway analysis suggested an important regulatory role these miRNAs played in different biological processes such as insulin signaling pathway, type 2 diabetes mellitus, porphyrin and chlorophyll metabolism ([Table 5](#pone-0101306-t005){ref-type="table"} and [Table 6](#pone-0101306-t006){ref-type="table"}).

10.1371/journal.pone.0101306.t005

###### Analysis of biological processes of the predicted miRNAs targets by GOstat.

![](pone.0101306.t005){#pone-0101306-t005-5}

  miRNAs                                   GO process                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Target genes                                                                                                                                                                                                                                                                                                                                                                                                                                                      Count     \%     *P*-value
  --------------- ------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- -------- -----------
  hsa-miR-497               GO:0043549:regulation of kinase activity                                                                                                                                                                                                                                                                                                                                                                                                                  PPP2R1A, MADD, PTPLAD1, DRD5, PDCD4, CDC25A, CDC25B, CBLC, TARBP2, PRKAR2A, APP, TSPYL2, DUSP9, HTR2A                                                                                                                                                                                                                                                                                                                                                                                                           14     0.3688    0.04444
                          GO:0007249:I-kappaB kinase/NF-kappaB cascade                                                                                                                                                                                                                                                                                                                                                                                                                                                  PTPLAD1, SNIP1, TLR1, IKBKB, TNIP2                                                                                                                                                                                                                                                                                                                                                                                                                                             5     0.1317    0.04600
                                 GO:0031980:mitochondrial lumen                                                                                                                                                                                                                                                                                                                                                                                                                                     GLS2, MRPL40, PDPR, FECH, HARS2, TMLHE, CARS2, YARS2, AK3L1, LRPPRC, KARS                                                                                                                                                                                                                                                                                                                                                                                                                         11     0.2898    0.02395
                                    GO:0005739:mitochondrion                                                                                                                                                                                                                                                                                                                                                        MRPL40, ACOX1, D2HGDH, CCDC19, NLRX1, AK3L1, KCNJ11, KARS, GLS2, GPX1, GSR, HTRA2, CISD3, SLC25A22, HARS2, SLC25A2, BDH2, AATK, PDPR, PPP2R1A, TRMU, FECH, NOL3, MRPS2, MMAB, RAB40AL, UCP2, TMLHE, SLC25A35, CARS2, YARS2, ALKBH3, LRPPRC                                                                                                                                                                                                                                                                                                                                        33     0.8693    0.03916
  hsa-miR-638                   GO:0009611:response to wounding                                                                                                                                                                                                                                                                                                                                                                                                                                                CCL11, MYF6, GPX1, TNFRSF1B, F10, MGLL, HOXB13, IL11                                                                                                                                                                                                                                                                                                                                                                                                                                    8     0.9335    0.00599
                    GO:0010740:positive regulation of protein kinase cascade                                                                                                                                                                                                                                                                                                                                                                                                                                                  GPX1, F10, BST2, IL11                                                                                                                                                                                                                                                                                                                                                                                                                                                    4     0.4667    0.03180
                                    GO:0031099:regeneration                                                                                                                                                                                                                                                                                                                                                                                                                                                                     MYF6, GPX1, NR4A3                                                                                                                                                                                                                                                                                                                                                                                                                                                      3     0.3501    0.03308
  hsa-miR-1260           GO:0051252:regulation of RNA metabolic process                                                                                                                                                                                                                                        ZNF583, SNIP1, PDX1, ZNF253, SKAP1, IL11, APP, GFI1B, RAB26, SLA2, OTX1, ARID5A, SOX12, HDAC10, FOSB, NPAS4, SPEN, UBN1, ZNF192, ZNF786, MED8, SERBP1, TGIF2, CUX1, TFAP2E, MAPRE3, MED1, CARHSP1, FOXM1, HOXB13, FHL2, ZNF367, NEDD8, ZNF177, SUFU, ZNF615, ZNF169, TNFRSF1B, TSC22D2, TCEA3, HEXIM2, LHX1, OVOL1, GATAD2B, ZNF426, ZNF701, FOXD4, SIM2, CHD3, MYF6, ESRRA, ZNF565, CREBZF, TAF8, NR4A1, ZNF221, NR4A3, ZNF763, RFX3, MESP2, NCOR2                                                                                                                                                                                                                                    61     1.5204    0.00323
                             GO:0045449:regulation of transcription                                                                                                                                                                        ZNF583, SNIP1, PDX1, ZNF253, PDCD4, CBX7, SKAP1, IL11, ARHGAP22, BZW1, APP, LBH, GFI1B, MED29, RAB26, SSBP2, POGZ, OTX1, SLA2, SOX12, ARID5A, HDAC10, FOSB, HDAC11, SPEN, NPAS4, UBN1, CCNL2, ZNF192, CCR6, PRDM4, ZNF786, MED8, PARP14, ZNF384, ERN2, TGIF2, CUX1, TFAP2E, MAPRE3, MED1, CARHSP1, FOXM1, TRIB3, HOXB13, FHL2, ZNF367, NEDD8, ZNF177, ZNF615, SUFU, ZNF169, TSC22D2, TCEA3, HEXIM2, LHX1, OVOL1, GATAD2B, ZNF426, RNF10, ZNF701, FOXD4, CHD3, SIM2, MYF6, SSRP1, ESRRA, ZBTB46, ZNF565, CREBZF, TAF8, NR4A1, ZNF221, NR4A3, ZNF629, PHF19, ZNF763, RFX3, IKBKB, MESP2, NCOR2                                                                                                                                                               80     1.9940    0.00686
                                     GO:0043167:ion binding                     SLC13A5, ZNF583, ZNRF1, ZNF253, TTL, APOBEC3C, APOBEC3D, MAP3K5, APP, CISD3, CDH23, RET, CAPNS2, FECH, PDXK, CRTAC1, BSN, RNASEH2A, WDR92, ZNF192, PRDM4, ZNF786, EIF2S2, ZNF384, UNC13A, NEK3, ZNF615, KCNJ1, RPS27, ZNF428, LHX1, OVOL1, RNF168, RNF10, ZNF426, STK19, GABRP, GIT1, NPLOC4, ESRRA, ZBTB46, B4GALT2, SETDB2, NR4A1, ZNF221, NR4A3, ACACB, ATP13A3, CYB561, PRPSAP2, ZNF629, TRIM56, KCNJ9, TMLHE, ZNF385D, SPTA1, TRAFD1, GLRA1, MLPH, GLRA3, CYP11B2, PDIA4, KCNJ11, KCNIP1, USP19, SMAP2, GFI1B, STAC2, TRIM9, DBR1, NSF, NT5C, POGZ, MICAL3, RPH3AL, CYB5B, ARL3, MYRIP, MAP3K15, ZNF691, TAF15, ERN2, CA4, CLCNKA, ZNF367, FHL2, EGLN2, ZNF177, BEST4, ZNF169, CYB561D1, TCEA3, CALML3, MMACHC, PRRG2, RASGRP2, DTNB, ENO2, MT1E, GATAD2B, GALNT11, ZNF701, CHD3, MT1M, NOS1, ZNF565, TRIM29, TRIM25, CYP4F8, RPS6KA3, FBLN1, RASSF5, PHF19, CDH15, ARSA, SCN4B, SUMF2, ZNF763, ALKBH3, RNF40    120    2.9910    0.03602
  hsa-miR-1260b          GO:0051252:regulation of RNA metabolic process                                                                                                                                                                                                                                        ZNF583, SNIP1, PDX1, ZNF253, SKAP1, IL11, APP, GFI1B, RAB26, SLA2, OTX1, ARID5A, SOX12, HDAC10, FOSB, NPAS4, SPEN, UBN1, ZNF192, ZNF786, MED8, SERBP1, TGIF2, CUX1, TFAP2E, MAPRE3, MED1, CARHSP1, FOXM1, HOXB13, FHL2, ZNF367, NEDD8, ZNF177, SUFU, ZNF615, ZNF169, TNFRSF1B, TSC22D2, TCEA3, HEXIM2, LHX1, OVOL1, GATAD2B, ZNF426, ZNF701, FOXD4, SIM2, CHD3, MYF6, ESRRA, ZNF565, CREBZF, TAF8, NR4A1, ZNF221, NR4A3, ZNF763, RFX3, MESP2, NCOR2                                                                                                                                                                                                                                    61     1.5204    0.00323
                           GO:0007242:intracellular signaling cascade                                                                                                                                                                                                                                                                                                            FGFR1, CARHSP1, RAB9A, RAB3D, PTPLAD1, DRD5, SNIP1, MAPKAPK3, FHL2, EGLN2, PDX1, RAB42, MAP3K5, DIRAS1, PRKAR2A, KISS1R, STAC2, RASGRP2, RAB26, TNIP2, LTB, GDI1, RET, C5AR1, PIK3C2B, SLA2, STMN4, NFKBIL1, DEPDC5, ARL3, RASL11B, RASSF5, RPS6KA3, RAB37, CNIH3, BBC3, SGSM3, RAB17, ASB1, IKBKB, UNC13A, MED1                                                                                                                                                                                                                                                                                                     42     1.0469    0.01837
  hsa-miR-3125                      GO:0006350:transcription                                                                                                                                                                                                                                                                                                                                          RNASEK, FOXM1, CBX4, TTLL5, ZNF367, ZNF177, CBX7, ZNF615, DPF1, ZNF169, GFI1B, OVOL1, GATAD2B, TWIST2, FOXD4, CHD3, ZNF548, ZBTB46, BRF2, TRIM29, SOX12, CDK9, DACH1, NR4A3, SPEN, HDAC11, HMGA1, NRIP2, CCR6, PRDM4, MED8, PARP14, ZNF384, RFX3, LRPPRC, PUF60, MED1                                                                                                                                                                                                                                                                                                                           37     1.9004    0.01354
  hsa-miR-3195               GO:0002064:epithelial cell development                                                                                                                                                                                                                                                                                                                                                                                                                                                               AGPAT6, HOXB13                                                                                                                                                                                                                                                                                                                                                                                                                                                       2     0.9009    0.02456
                               GO:0004672:protein kinase activity                                                                                                                                                                                                                                                                                                                                                                                                                                                           FGFR1, LMTK2, CDK9, IKBKB                                                                                                                                                                                                                                                                                                                                                                                                                                                  4     1.8018    0.04223
  hsa-miR-4284     GO:0008629:induction of apoptosis by intracellular signals                                                                                                                                                                                                                                                                                                                                                                                                                                                CUL3, CUL2, BBC3, CIDEA                                                                                                                                                                                                                                                                                                                                                                                                                                                   4     0.1980    0.02512
  hsa-miR-4313               GO:0045449:regulation of transcription                                                                                                                                                                                                                                                                                                                                 CARHSP1, ZNF583, GDF7, HOXB13, CBX7, PDCD4, IL11, DPF1, CCNE1, TSPYL2, MED29, OVOL1, TWIST2, ESRRA, ZBTB46, POGZ, BRF2, ARID5A, HDAC11, DACH1, ZNF497, HMGA1, CCNL2, ZNF629, TARBP2, PRDM4, MED8, PARP14, ZNF384, ZNF763, TGIF2, JAK3, CUX1, MAPRE3, MESP2, LRPPRC, NCOR2                                                                                                                                                                                                                                                                                                                         37     2.2534    0.02350

10.1371/journal.pone.0101306.t006

###### Pathway analysis of the predicted miRNAs using DAVID Bioinformatics software.

![](pone.0101306.t006){#pone-0101306-t006-6}

  Category                                          Term                        Count      \%       *P*-value                               Genes
  ---------------------------- ----------------------------------------------- ------- ----------- ----------- ----------------------------------------------------------------
  hsa-miR-497 KEGG-PATHWAY           hsa04910:Insulin signaling pathway           9     0.237092     0.00939    CBLC, PRKAR2A, EXOC7, SLC2A4, FASN, ACACB, PIK3R3, IKBKB, LIPE
  hsa-miR-195 KEGG_PATHWAY           hsa04910:Insulin signaling pathway           9     0.2426530    0.00802    CBLC, PRKAR2A, EXOC7, SLC2A4, FASN, ACACB, PIK3R3, IKBKB, LIPE
  hsa-miR-1260b KEGG-PATHWAY         hsa04930:Type II diabetes mellitus           5     0.124626     0.02158                 SLC2A4, PDX1, PIK3R3, IKBKB, KCNJ11
  hsa-miR-3195 KEGG-PATHWAY          hsa04910:Insulin signaling pathway           3     1.351351     0.00405                         CALML3, FASN, IKBKB
  hsa-miR-4313 KEGG-PATHWAY     hsa00860:Porphyrin and chlorophyll metabolism     3     0.182704     0.03826                          HMOX2, ALAD, BLVRB

Comment {#s4}
=======

Nephrolithiasis is a multi-factorial disorder which, in many patients, results in renal deposition of calcium oxalate. There are various theories in the pathogenesis of nephrolithiasis. One favored theory proposes that oxalate-induced injury to renal tubular epithelial cells promotes adherence of calcium oxalate crystals. The renal damage is closely linked to the degree of COM crystals accumulation in the kidney and most likely results from a COM-induced injury to proximal tubular cells. Therefore, we used HK-2 cells exposure to COM crystals to simulate the process of renal damage.

In our study, the first step demonstrated that COM crystals had concentration-dependent toxicity on HK-2 cells. Based on these results, we found a proper concentration for our subsequent experiments.

HK-2 cells are a line of human proximal tubular epithelial cells immortalized by using the E6/E7 genes of human papilloma virus (HPV 16) [@pone.0101306-Ryan1]. These cells retain the characteristics of proximal renal tubular epithelium and have been successfully used as an in vitro model system to represent the human kidney epithelial cells. HK-2 cells, instead of other cells, were used in this study because the proximal tubule is the major site for renal oxalate handing [@pone.0101306-Shum1]. Moreover, HK-2 cell line has been frequently used in several previous studies on COM crystal-induced renal tubular cell injury [@pone.0101306-Koul1], [@pone.0101306-Chen1], [@pone.0101306-Huang1]. However, HK-2 cells are not normal proximal tubular cells, which is also one limitation of the present study. In our future study, we will focus on normal proximal tubular cells.

Over the past two decades, many studies [@pone.0101306-Koul2], [@pone.0101306-Lieske1] have demonstrated that calcium oxalate interactions with renal epithelial cells result in a program of events, including changes in gene expression and cell dysfunction. Calcium oxalate toxicity will induce new gene expression and protein synthesis. Besides, the renal epithelial cells exposed to oxalate must be able to adapt to oxalate stress. Many signaling pathways, including p38 MAPK and JNK, are activated in renal tubular epithelium in response to oxalate and COM crystals [@pone.0101306-Koul2], [@pone.0101306-Chaturvedi1]. However, previous studies have mainly focused on DNA, mRNA and protein levels. Koul et al utilized gene chips to explain the global gene expression changes in human renal epithelial cells after exposure to oxalate. Their results showed that renal cells exposed to oxalate resulted in the regulation of genes that were associated with specific molecular function, biological processes, and other cellular components [@pone.0101306-Koul1]. In proteomic insights, chen et al identified 12 differentially expressed proteins in HK-2 cells induced by oxalate and COM crystals. These proteins were associated with cell propagation and apoptosis, protein synthesis and cellular energy metabolism [@pone.0101306-Chen1]. In another study, 53 proteins were altered in MDCK cells after exposure to high-dose COM crystals for 48 h. These proteins were involved in protein biosynthesis, ATP synthesis, cell cycle regulator, cellular structure and signal transduction [@pone.0101306-Thongboonkerd1]. Besides these mechanisms, miRNA is a newly identified mechanism, and this field is potentially promising. Thus far, several studies have investigated miRNA expression patterns in prostate and renal cancers in urology [@pone.0101306-Mahn1], [@pone.0101306-Zhang2], [@pone.0101306-Zhou1]. To explore this new field in stone formation, we examined the miRNA expression profiles of HK-2 cells treated with COM crystals, and identified some deregulated miRNAs. In this study, we dentified some deregulated miRNAs which were involved in biological processes, apoptosis, intracellular signaling cascade, protein kinase activity, etc. The results were confirmed by qRT-PCR.

To study the involvement of miRNA-mediated regulation of gene expression in HK-2 cells, we analyzed whether the genes from mRNA microarray were the predicted targets of the deregulated miRNAs, and finally, the results showed that 114 genes were the predicted targets of the 12 differential miRNAs. hsa-miR-642b, hsa-miR-4313 and hsa-miR-4284 were related to cell death, mitochondrion and metabolic process; hsa-miR-497, hsa-miR-4313 and hsa-miR-195 were related to programmed cell death; hsa-miR-497, hsa-miR-195 and hsa-miR-371-5p were related to lactate dehydrogenase; hsa-miR-195 was related to mitochondrial function; hsa-miR-497, hsa-miR-3125, hsa-miR-1260b and hsa-miR-195 were related to protein kinase.

According to the GO analysis, hsa-miR-497 and hsa-miR-3195 may be involved in the regulation of protein kinase activity; hsa-miR-1260b may be involved in intracellular signaling cascade; hsa-miR-1260 and hsa-miR-1260b may be involved in the regulation of RNA metabolic process; hsa-miR-4313 and hsa-miR-1260 may be involved in the regulation of transcription; hsa-miR-497 may be involved in I-kappaB kinase/NF-kappaB cascade; hsa-miR-4284 may be involved in apoptosis by intracellular signals; hsa-miR-638 may be involved in response to wounding; hsa-miR-497 may be involved in mitochondrion function. In previous reports, MAPK signaling pathways and NF-kappaB were always related to the COM crystals-cell interaction. Peerapen et al indicated that COM crystals caused tight junction disruption in distal renal tubular epithelial cells through p38 MAPK activation [@pone.0101306-Peerapen1]. Chaturvedi et al found that oxalate exposure resulted in re-initiation of the DNA synthesis, altered gene expression and apoptosis. Exposure to oxalate rapidly stimulated robust phosphorylation and activation of p38 MAPK. Oxalate exposure induced modest activation of c-Jun. p38 MAPK activity was essential for the effects of oxalate on re-initiation of DNA synthesis [@pone.0101306-Chaturvedi2]. Oxalate inhibited renal proximal tubule cell proliferation via oxidative stress and p38 MAPK/JNK signaling pathways [@pone.0101306-Han1]. Tozawa et al demonstrated that oxalate induced OPN expression by activating NF-kappaB in renal tubular cells [@pone.0101306-Tozawa1]. Koul et al suggested that the interaction of COM crystals with renal cells had been proved to result in altered gene expression and re-initiation of DNA synthesis [@pone.0101306-Koul3]. Another study indicated that the exposure to high levels of COM crystals was injurious to renal epithelial cells [@pone.0101306-Khaskhali1]. Under transmission electron microscopy, proximal tubular cells were capable of internalizing COM crystals since COM could interact with mitochondria directly. Treatment with COM crystals induced a significant decrease in the mitochondrial membrane potential [@pone.0101306-Hovda1]. Our studies found that the genes involved in MAPK signaling pathways, NF-kappaB and mitochondrial membrane potential were also regulated by miRNAs as mentioned before.

Pathway analysis based on the differentially expressed mRNAs revealed significant pathways with *P*-values\<0.05, including the insulin signaling pathway, type 2 diabetes mellitus, porphyrin and chlorophyll metabolism pathway. In a preceding study, kidney stone disease was related to the history of T2DM (OR: 2.44; 95% CI, 1.84--3.25) and that of insulin use (OR: 3.31; 95% CI, 2.02--5.45). They concluded that the history of T2DM, the use of insulin, FPI and HbA~1~c remained significantly associated with kidney stone disease [@pone.0101306-Weinberg1]. In a 5-year follow-up, patients who received a diagnosis of urinary calculi were at an increased risk for diabetes mellitus [@pone.0101306-Chung1]. Some studies demonstrated an increase in urinary calcium and phosphorus excretion in patients with T2DM [@pone.0101306-Thalassinos1]. Recent investigations had highlighted that stone formers with T2DM had increased urinary oxalate excretion [@pone.0101306-Eisner1]. The mechanism between stone disease and diabetes is still unknown, but recent literature has indicated that the production of reactive oxygen species (ROS) and development of oxidative stress (OS) might be in common pathways [@pone.0101306-Khan2]. In our studies, pathway analysis indicated miRNAs mentioned previously might be involved in the insulin signaling pathway and type 2 diabetes mellitus. However, a lot of works still need to be done to validate the connection between stone disease and diabetes.

It should be noted that we evaluated changes in miRNA in HK-2 cells after 24 h exposure to 1 mmol/L of COM crystals. Although we successfully identified several miRNAs that were altered in this setting, the evaluation of changes caused by higher doses of COM crystals and at later time points would lead to an understanding of "late responses" in proximal renal tubular cells. Moreover, the study of miRNA changes in distal tubular cells would provide more insights into the molecular mechanisms of COM crystal-induced toxicity.

Conclusions {#s5}
===========

In summary, we successfully identified a set of miRNAs in HK-2 cells that were altered by COM crystal-induced toxicity. Alterations in several of these miRNAs could help us further explore the mechanistic pathways of COM crystal-induced toxicity in renal tubular epithelial cells. However, the functional significance of some altered miRNAs remains unclear and should be further elucidated in order to gain a better understanding of the detrimental changes and the adaptive responses in these cells during COM crystal adhesion, and finally to unravel the pathogenic mechanisms of kidney stone disease.
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